Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 27, 2025 11:37 ET | Source: Research and Markets

United States Anxiety Disorders and Depression Treatment Market Research Report 2025-2033: Developments in Medicinal Therapies, and Raising Awareness of Mental Health Issues and Reducing Stigma

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "United States Anxiety Disorders and Depression Treatment Market Report by Product, Indication, States and Company Analysis, 2025-2033" report has been...
October 15, 2025 11:24 ET | Source: HMNC Holding GmbH

Ketabon Presents New Data Showing Antidepressant Effects of Oral Ketamine (KET01) Are Independent of Dissociation

Ketabon, a JV between HMNC and Develco, shared new post hoc Phase 2 data for oral ketamine (KET01) in treatment-resistant depression (TRD)
September 30, 2025 04:07 ET | Source: Research and Markets

Depressive Disorders Market Industry Trends and Forecasts, 2035 - 65+ Candidates in Pipeline, $3 Billion in Investments and Rising Focus on Digital Therapeutics Drive Growth

Dublin, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The "Depressive Disorders Market Industry Trends and Global Forecasts to 2035 - Distribution by Type of Depression, Type of Molecule, Type of Therapy,...
September 09, 2025 10:24 ET | Source: Research and Markets

Anxiety Disorders and Depression Treatment Market Growth Trends Report 2025-2033 | Pharmacological and Non-Pharmacological Innovations Strengthen Global Mental Health Support and Treatment Options

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "Anxiety Disorders and Depression Treatment Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ...
June 05, 2025 09:31 ET | Source: Research and Markets

Psychedelic Drugs Markets and Companies Analysis 2025-2029: Shares for Ketamine, GHB, MDMA, Psilocybin, and Other Drugs

Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Psychedelic Drugs Market 2025-2029" has been added to ResearchAndMarkets.com's offering. The psychedelic drugs market is poised for substantial...
May 20, 2025 07:00 ET | Source: Beckley Psytech

Beckley Psytech announces positive topline data from Part 2 of its Phase IIa study of BPL-003 (intranasal 5-MeO-DMT benzoate) in combination with SSRIs for treatment resistant depression

Positive results show that a single dose of BPL-003, administered adjunctively to SSRIs, produced a rapid and long-lasting antidepressant effect for up to three months after dosing.BPL-003 was...
April 08, 2025 10:43 ET | Source: Research and Markets

Antidepressant Drugs Market to Double by 2034 Driven by Mental Health Awareness and Treatment Innovation | Telemedicine and Online Pharmacies Reshape Global Distribution Landscape

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Antidepressant Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
March 04, 2025 10:56 ET | Source: Research and Markets

Postpartum Depression Pipeline Revealed in 2025 Forecast Report Featuring GH Research, Reunion Neuroscience, Lipocine, and Brii Biosciences

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Postpartum Depression - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering "Postpartum Depression - Pipeline...
August 30, 2024 04:15 ET | Source: Research and Markets

Anxiety Disorders and Depression Treatment Global Market Report 2024-2032: Sturdy Medication Pipelines to Support Development, Economic Cost of Mental Illnesses to Drive Demand

Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032" report has...
February 07, 2024 04:21 ET | Source: Clerkenwell Health

Trial of new psychedelic drug seeks patients with Treatment Resistant Depression

London, Feb. 07, 2024 (GLOBE NEWSWIRE) -- An international clinical trial which is investigating a novel synthetic formulation of the psychedelic substance 5-MeO-DMT (also known as Mebufotenin) for...